Skip to menu Skip to content Skip to footer

2025

Journal Article

Endpoint selection in autosomal dominant polycystic kidney disease clinical trials

St Pierre, Kitty, El-Damanawi, Ragada, Jefferis, Julia, Johnson, David W., Hawley, Carmel M., Staatz, Christine E., Viecelli, Andrea K. and Mallett, Andrew J. (2025). Endpoint selection in autosomal dominant polycystic kidney disease clinical trials. Kidney International Reports, 10 (11), 3773-3784. doi: 10.1016/j.ekir.2025.09.024

Endpoint selection in autosomal dominant polycystic kidney disease clinical trials

2025

Conference Publication

Exploring patient experience of potential tacrolimus toxicity and novel approaches to measuring tacrolimus exposure after adult kidney transplantation.

King, C., Cossart, A. R., Isbel, N. M., Campbell, S. B., Taing, M., Leary, D., Houlihan, V. and Staatz, C. E. (2025). Exploring patient experience of potential tacrolimus toxicity and novel approaches to measuring tacrolimus exposure after adult kidney transplantation.. Transplant Nurses Association National Conference, Brisbane, QLD Australia, 23-24 October 2025.

Exploring patient experience of potential tacrolimus toxicity and novel approaches to measuring tacrolimus exposure after adult kidney transplantation.

2025

Journal Article

Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration–Time Curve in Steroid-Free Kidney Transplant Patients

Agergaard, Katrine, Thiesson, Helle C., Carstens, Jan, Staatz, Christine E., Järvinen, Erkka, Nielsen, Flemming, Christensen, Heidi Dahl, Juul-Sandberg, Rikke, Brøsen, Kim, Stage, Tore Bjerregaard, Kjellsson, Maria C. and Bergmann, Troels K. (2025). Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration–Time Curve in Steroid-Free Kidney Transplant Patients. Basic and Clinical Pharmacology and Toxicology, 137 (1) e70056. doi: 10.1111/bcpt.70056

Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration–Time Curve in Steroid-Free Kidney Transplant Patients

2025

Journal Article

Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients

Agergaard, Katrine, Thiesson, Helle C., Carstens, Jan, Staatz, Christine E., Järvinen, Erkka, Nielsen, Flemming, Christensen, Heidi Dahl, Juhl-Sandberg, Rikke, Brøsen, Kim, Stage, Tore Bjerregaard, Andersen, Dorte Terp, Kjellsson, Maria C. and Bergmann, Troels K. (2025). Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients. British Journal of Clinical Pharmacology, 91 (3), 761-773. doi: 10.1111/bcp.16277

Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients

2025

Journal Article

Examining different methods to assess busulfan exposure in pediatric hematopoietic stem cell transplant recipients

Thompson, Maxwell, Staatz, Christine E., Fraser, Christopher J., Hennig, Stefanie and Lawson, Rachael (2025). Examining different methods to assess busulfan exposure in pediatric hematopoietic stem cell transplant recipients. Therapeutic Drug Monitoring, 47 (3), 421-426. doi: 10.1097/ftd.0000000000001304

Examining different methods to assess busulfan exposure in pediatric hematopoietic stem cell transplant recipients

2025

Journal Article

Examining whole blood, total and free plasma tacrolimus in elderly kidney transplant recipients

Cossart, Amelia R., Isbel, Nicole M., Campbell, Scott B., McWhinney, Brett and Staatz, Christine E. (2025). Examining whole blood, total and free plasma tacrolimus in elderly kidney transplant recipients. Therapeutic Drug Monitoring, 47 (1), 161-168. doi: 10.1097/ftd.0000000000001274

Examining whole blood, total and free plasma tacrolimus in elderly kidney transplant recipients

2025

Journal Article

Population pharmacokinetics of telmisartan in healthy subjects and hypertensive patients

Jeong, In Hwan, Ryu, Sooyoon, Han, Nayoung, Staatz, Christine E. and Baek, In-hwan (2025). Population pharmacokinetics of telmisartan in healthy subjects and hypertensive patients. Clinical Pharmacokinetics, 64 (2) 116169, 285-295. doi: 10.1007/s40262-024-01471-3

Population pharmacokinetics of telmisartan in healthy subjects and hypertensive patients

2025

Conference Publication

Altered pharmacokinetics and pharmacodynamics during infection in the post-transplant period

Staatz, C. E. (2025). Altered pharmacokinetics and pharmacodynamics during infection in the post-transplant period. International Association of Therapeutic Drug Monitoring and Clinical Toxicology congress, Singapore, 21-24 September 2024.

Altered pharmacokinetics and pharmacodynamics during infection in the post-transplant period

2025

Conference Publication

Antiemetic prescribing and documentation in paediatric oncology patients receiving chemotherapy at the Queensland Children’s Hospital: is there scope for improvement?

Kaur, S., Staatz, C.E. and Lawson, R. (2025). Antiemetic prescribing and documentation in paediatric oncology patients receiving chemotherapy at the Queensland Children’s Hospital: is there scope for improvement?. Children's Hospital Queensland Paediatric Allied Health Research Conference, Brisbane, QLD, Australia, 18 November 2025.

Antiemetic prescribing and documentation in paediatric oncology patients receiving chemotherapy at the Queensland Children’s Hospital: is there scope for improvement?

2025

Conference Publication

Patient-reported changes in symptoms upon adult kidney transplantation

King, C., Isbel, N. M., Campbell, S. B., Cossart, A. R., Leary, D., Taing, M. and Staatz, C. E. (2025). Patient-reported changes in symptoms upon adult kidney transplantation. TSANZ Annual Scientific meeting 2025, Canberra, ACT Australia, 22-24 June 2025.

Patient-reported changes in symptoms upon adult kidney transplantation

2025

Conference Publication

Balancing risk and cost: Real-world use of defibrotide in paediatric AML transplantation

Harbeck, D., Staatz, C.E., Healy, H. and Lawson, R.A. (2025). Balancing risk and cost: Real-world use of defibrotide in paediatric AML transplantation. Children's Hospital Queensland Paediatric Allied Health Research Conference, Brisbane, QLD, Australia, 18 November 2025.

Balancing risk and cost: Real-world use of defibrotide in paediatric AML transplantation

2025

Book Chapter

Considering kidney and liver function when prescribing and reviewing medicines in older people

St Pierre, Kitty I., Hill, Katherine and Staatz, Christine E. (2025). Considering kidney and liver function when prescribing and reviewing medicines in older people. Polypharmacy and geriatrics. (pp. 207-229) edited by Nagham J. Ailabouni. Cham, Switzerland: Springer Cham. doi: 10.1007/978-3-031-77314-3_8

Considering kidney and liver function when prescribing and reviewing medicines in older people

2024

Journal Article

Does age influence immunosuppressant drug pharmacokinetics in kidney transplant recipients?

Cossart, Amelia R., Isbel, Nicole M., Campbell, Scott B., McWhinney, Brett and Staatz, Christine E. (2024). Does age influence immunosuppressant drug pharmacokinetics in kidney transplant recipients?. European Journal of Drug Metabolism and Pharmacokinetics, 49 (6), 751-761. doi: 10.1007/s13318-024-00914-3

Does age influence immunosuppressant drug pharmacokinetics in kidney transplant recipients?

2024

Journal Article

Preparedness of pharmacy students and preceptors for work integrated learning in an undergraduate Pharmacy program

Quach, Thien An, Staatz, Christine, Lee, Jane, Fejzic, Jasmina and Hardman, Caitlin (2024). Preparedness of pharmacy students and preceptors for work integrated learning in an undergraduate Pharmacy program. The Australian Pharmacy Students' Journal, 3 (2), 15-29. doi: 10.55136/apsj326

Preparedness of pharmacy students and preceptors for work integrated learning in an undergraduate Pharmacy program

2024

Journal Article

Metformin for preventing the progression of chronic kidney disease

El-Damanawi, Ragada, Stanley, Isabelle Kitty, Staatz, Christine, Pascoe, Elaine M., Craig, Jonathan C., Johnson, David W., Mallett, Andrew J., Hawley, Carmel M., Milanzi, Elasma, Hiemstra, Thomas F. and Viecelli, Andrea K. (2024). Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, 2024 (6) CD013414, CD013414. doi: 10.1002/14651858.cd013414.pub2

Metformin for preventing the progression of chronic kidney disease

2024

Journal Article

Efficacy and safety of fibroblast growth factor‐21 analogs for the treatment of metabolic dysfunction‐associated steatohepatitis: a systematic review and meta‐analysis

Jeong, Changhyeon, Han, Nayoung, Jeon, Nakyung, Rhee, Su‐jin, Staatz, Christine E., Kim, Min‐Soo and Baek, In‐hwan (2024). Efficacy and safety of fibroblast growth factor‐21 analogs for the treatment of metabolic dysfunction‐associated steatohepatitis: a systematic review and meta‐analysis. Clinical Pharmacology and Therapeutics, 116 (1), 72-81. doi: 10.1002/cpt.3278

Efficacy and safety of fibroblast growth factor‐21 analogs for the treatment of metabolic dysfunction‐associated steatohepatitis: a systematic review and meta‐analysis

2024

Journal Article

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

Stanley, I. Kitty, Palma, Anton M., Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Staatz, Christine E. and Mallett, Andrew J. (2024). A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. Journal of Nephrology, 37 (5), 1417-1419. doi: 10.1007/s40620-024-01906-x

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

2024

Journal Article

Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis

Na, Hyun-jin, Jeon, Nakyung, Staatz, Christine E, Han, Nayoung and Baek, In-hwan (2024). Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis. SLEEP, 47 (2) zsad293, 1-11. doi: 10.1093/sleep/zsad293

Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis

2024

Journal Article

A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline

Stanley, Kitty, Mallett, Andrew J., Viecelli, Andrea K., Hawley, Carmel M., Staatz, Christine E., Johnson, David W. and Milanzi, Elasma (2024). A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline. Kidney International Reports, 9 (5), 1525-1527. doi: 10.1016/j.ekir.2024.02.011

A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline

2024

Conference Publication

Prediction of intracellular tacrolimus concentrations in stabile kidney transplanted adults using a population pharmacokinetic modelling approach.

Katrine Agergaard, K., Thiesson, H.C., Carstens, J., Staatz, C.E., Järvinen, E., Nielsen, F., Christensen, H.D., Juhl-Sandberg, R., Brøsen, K., Stage, T.B., Andersen, D.T., Kjellsson, M.C. and Bergmann, T.K. (2024). Prediction of intracellular tacrolimus concentrations in stabile kidney transplanted adults using a population pharmacokinetic modelling approach.. Scandinavian Transplantation Society, Aarhus, Denmark, 29-31 May 2024.

Prediction of intracellular tacrolimus concentrations in stabile kidney transplanted adults using a population pharmacokinetic modelling approach.